Results 261 to 270 of about 422,013 (303)

First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial

Lancet Oncology, The, 2023
Marina Nechaeva, Manika Kaul, Emmanuel Okoye   +2 more
exaly  

Continuing Progress

Contemporary Psychology: A Journal of Reviews, 1987
openaire   +1 more source

The “Green Journal” — Progress and continuity

The American Journal of Medicine, 1980
A J, Antenucci, R B, Devereux
openaire   +2 more sources

CONTINUITY AND PROGRESSION.

The Lancet, 1923
openaire   +1 more source

Continued Progress and an Ambitious Goal

DNA and Cell Biology, 2012
openaire   +2 more sources

Continued EGFR-TKI with concurrent radiotherapy to improve time to progression (TTP) in patients with locally progressive non-small cell lung cancer (NSCLC) after front-line EGFR-TKI treatment

Clinical and Translational Oncology, 2017
J Sun, Lu D
exaly  

Continued Progress in the Treatment of Histoplasmosis

Chest, 1970
openaire   +2 more sources

Continued Smoking Exacerbates but Cessation Ameliorates Progression of Early Type 2 Diabetic Nephropathy

American Journal of the Medical Sciences, 2008
Cathy Hudson, Donald E Wesson, Jan Simoni   +2 more
exaly  

Continued drug use and other cofactors for progression to AIDS among injecting drug users

Aids, 1994
J Roy Robertson, J R Robertson
exaly  

Evaluation of Possible Effects of Continued Drug Use on HIV Progression among Women

International Journal of STD and AIDS, 2004
Anne M Rompalo, Joseph B Margolick, Homayoon Farzadegan   +2 more
exaly